[{"address1": "P.O. Box 134", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 725 1500", "website": "https://www.galeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. J. Mel Sorensen M.D.", "age": 66, "title": "CEO, President & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 632637, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Evans Stacey Esq.", "age": 58, "title": "Chief Legal & Compliance Officer and Secretary", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 9, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "open": 0.0541, "dayLow": 0.0541, "dayHigh": 0.0541, "regularMarketOpen": 0.0541, "regularMarketDayLow": 0.0541, "regularMarketDayHigh": 0.0541, "beta": 1.949, "forwardPE": -0.045967743, "volume": 100, "regularMarketVolume": 100, "averageVolume": 320739, "averageVolume10days": 213070, "averageDailyVolume10Day": 213070, "bid": 0.0536, "ask": 0.0599, "marketCap": 3100355, "fiftyTwoWeekLow": 0.051, "fiftyTwoWeekHigh": 0.29, "fiftyDayAverage": 0.06946, "twoHundredDayAverage": 0.141285, "trailingAnnualDividendYield": "NaN", "currency": "USD", "enterpriseValue": 144580752, "floatShares": 39936907, "sharesOutstanding": 54392200, "sharesShort": 2123783, "sharesShortPriorMonth": 2657537, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.31632, "heldPercentInstitutions": 0.01071, "shortRatio": 1.16, "shortPercentOfFloat": 0.052800003, "impliedSharesOutstanding": 54392200, "bookValue": -2.538, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -29105000, "trailingEps": -0.51, "forwardEps": -1.24, "enterpriseToEbitda": -5.828, "52WeekChange": -0.7298578, "SandP52WeekChange": 0.39389753, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "GRTX", "underlyingSymbol": "GRTX", "shortName": "Galera Therapeutics, Inc.", "longName": "Galera Therapeutics, Inc.", "firstTradeDateEpochUtc": 1573137000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9ff241d9-e75a-35e9-b4be-f64d9dbab88e", "messageBoardId": "finmb_225098093", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.057, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 10749000, "totalCashPerShare": 0.198, "ebitda": -24807000, "totalDebt": 152243008, "quickRatio": 5.056, "currentRatio": 5.627, "returnOnAssets": -0.48424998, "freeCashflow": -22482624, "operatingCashflow": -29944000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-28"}]